Financials data is unavailable for this security.
View more
Year on year Bio-Gene Technology Ltd grew revenues 4.19% from 681.04k to 709.55k while net income improved from a loss of 3.10m to a smaller loss of 2.41m.
Gross margin | -- |
---|---|
Net profit margin | -339.54% |
Operating margin | -339.60% |
Return on assets | -68.88% |
---|---|
Return on equity | -80.14% |
Return on investment | -79.31% |
More ▼
Cash flow in AUDView more
In 2024, cash reserves at Bio-Gene Technology Ltd fell by 780.97k. Cash Flow from Financing totalled 1.98m or 278.90% of revenues. In addition the company used 2.75m for operations while cash used for investing totalled 5.70k.
Cash flow per share | -0.0128 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0139 |
---|---|
Tangible book value per share | 0.0129 |
More ▼
Balance sheet in AUDView more
Current ratio | 8.49 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼